RNA molecule with potential impact on cancer treatment (G106481651)

Target Name: RNU2-54P

NCBI ID: G106481651

RNU2-54P

Other Name(s): RNA, U2 small nuclear 54, pseudogene

RNA molecule with potential impact on cancer treatment

RNA, U2 small nuclear 54 (RNU2-54P), is a small non-coding RNA molecule that plays a critical role in various cellular processes. It is a pseudogene, which means that it has a sequence identical to a gene but does not encode any functional RNA molecule. RNU2-54P is expressed in most tissues and cells of the human body, and it is involved in a wide range of cellular processes, including cell growth, apoptosis, and inflammation.

One of the key features of RNU2-54P is its ability to interact with other molecules in the cell. It has been shown to interact with various protein molecules, including Ku70, a nuclear protein that plays a role in regulating gene expression. Ku70 has been shown to physically interact with RNU2-54P, leading to the formation of a complex that is involved in the regulation of gene expression.

In addition to its role in gene regulation, RNU2-54P is also a potential drug target. Its interaction with Ku70 suggests that it may be a useful target for small molecule inhibitors that are designed to disrupt the interaction between Ku70 and RNA molecules. This could be useful for treating a wide range of diseases, including cancer, where the regulation of gene expression is often disrupted.

Another potential application of RNU2-54P is its use as a biomarker. Its expression has been shown to be regulated in a variety of tissues and cells, including cancer cells. This makes it a potential target for diagnostic tests that are designed to detect changes in the expression of RNU2-54P in response to specific therapeutic treatments. For example, if a patient has been treated with a drug that inhibits the interaction between Ku70 and RNA molecules, the expression of RNU2-54P in the patient's cancer cells may be expected to decrease. This could be an important diagnostic tool for monitoring the effectiveness of cancer treatments.

Overall, RNU2-54P is a fascinating molecule that has a wide range of potential applications in both research and medicine. Its ability to interact with other molecules in the cell and its potential as a drug target make it an attractive target for further research into its functions and potential uses. Further studies are needed to fully understand the role of RNU2-54P in cellular processes and its potential as a diagnostic tool.

Protein Name: RNA, U2 Small Nuclear 54, Pseudogene

The "RNU2-54P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNU2-54P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets